70 results
Thumbnail

D1.385 - Dupilumab Treatment Effects on Atopic Manifestations in Patients with Inborn Errors of Immunity

Thumbnail

D1.386 - Impact of dupilumab on allergen specific immunoglobulin E production

Thumbnail

D2.71 - Comprehensive approach to severe bronchial asthma: a case study and the role of biologic therapy

Thumbnail

D2.76 - When Eosinophilia Persists: Unmasking an Unexpected Diagnosis in a Dupilumab Treated Atopic Dermatitis Patient

Thumbnail

D2.78 - Hypersensitivity Reactions to Biologics in Patients with Th1- and Th17-Driven Immune-Mediated Diseases: A Series of Three Cases

Thumbnail

D2.93 - Differential effects of dupilumab in women with severe uncontrolled asthma

Thumbnail

D3.109 - Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis

Thumbnail

D3.344 - Biological therapy for severe chronic spontaneous urticaria associated with autoimmune atrophic gastritis

Thumbnail

D3.364 - Effect of Omalizumab on Inflammatory and Immune Biomarkers in Mast Cell-Mediated Angioedema

Thumbnail

D3.138 - Asthma remission in EGPA patients: applicability and concordance of the main international guidelines

Thumbnail

D3.23 - Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Thumbnail

D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis

Thumbnail

D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Thumbnail

D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria

Thumbnail

D3.283 - Taming the Unpredictable: Omalizumab’s Role in Idiopathic anaphylaxis and chronic spontaneous urticaria

Thumbnail

D3.29 - Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients

Thumbnail

D3.33 - Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management

Thumbnail

D3.358 - The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings

Thumbnail

D3.359 - Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment

Thumbnail

D3.362 - Use and safety of canakinumab during pregnancy